Home › Ligand Pharmaceuticals Inc. (LGND) Stock Rating Reaffirmed by Roth Capital
 

Keywords :   


Ligand Pharmaceuticals Inc. (LGND) Stock Rating Reaffirmed by Roth Capital

2016-04-11 07:30:57| Biotech - Topix.net

's stock had its "buy" rating restated by equities research analysts at Roth Capital in a research report issued to clients and investors on Saturday, MarketBeat reports. Other hedge funds have made changes to their positions in the company.

Tags: rating stock capital roth

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Tropical Storm Beryl Potential Storm Surge Flooding Map
05.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
05.07Tropical Storm Beryl Graphics
05.07Tropical Storm Beryl Graphics
05.07Tropical Storm Beryl Forecast Discussion Number 29
05.07Tropical Storm Beryl Wind Speed Probabilities Number 29
More »